Luo M - Search Results

1

The 100 Most-Cited Articles in the Field of Colorectal Diseases from 1955 to 2020: A Bibliometric Analysis.

Zhang C, Luo M, Zhu H, Zhou J, Miao L. Zhang C, et al. Among authors: luo m. Turk J Gastroenterol. 2022 Mar;33(3):221-232. doi: 10.5152/tjg.2021.20901. Turk J Gastroenterol. 2022. PMID: 35410856 Free PMC article. Review.

2

Biomarkers for predicting nucleos(t)ide analogs discontinuation and hepatitis B virus recurrence after drug withdrawal in chronic hepatitis B patients.

Luo M, Zhou B, Hou J, Jiang D. Luo M, et al. Hepatol Res. 2022 Apr;52(4):337-351. doi: 10.1111/hepr.13749. Epub 2022 Feb 21. Hepatol Res. 2022. PMID: 35089634 Review.

3

Editorial: tripartite motif 26 inhibits hepatitis B virus replication and its genetic polymorphism predicts response to interferon treatment-towards a better understanding of interferon responsiveness in chronic hepatitis B. Authors' reply.

Luo M, Jiang DK. Luo M, et al. Aliment Pharmacol Ther. 2022 Sep;56(6):1096-1097. doi: 10.1111/apt.17181. Aliment Pharmacol Ther. 2022. PMID: 35995749 No abstract available.

4

Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds.

Mai H, Xie H, Luo M, Hou J, Chen J, Hou J, Jiang DK. Mai H, et al. Among authors: luo m. Cancers (Basel). 2022 Jan 23;14(3):563. doi: 10.3390/cancers14030563. Cancers (Basel). 2022. PMID: 35158838 Free PMC article.

5

A genetic variant of CXCR4 predicts pegylated interferon-alpha treatment response in HBeAg-positive chronic hepatitis B patients.

Luo M, Dong C, Liang X, Na R, Zhou B, Hou J, Jiang D-K. Luo M, et al. J Clin Microbiol. 2024 Feb 14;62(2):e0139623. doi: 10.1128/jcm.01396-23. Epub 2024 Jan 23. J Clin Microbiol. 2024. PMID: 38259071 Free PMC article.

6

TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFNα treatment response of HBeAg-positive chronic hepatitis B Patients.

Luo M, Hou J, Mai H, Chen J, Chen H, Zhou B, Hou J, Jiang DK. Luo M, et al. Aliment Pharmacol Ther. 2022 Sep;56(5):878-889. doi: 10.1111/apt.17124. Epub 2022 Jul 24. Aliment Pharmacol Ther. 2022. PMID: 35872575

7

A functional variant of CD40 modulates clearance of hepatitis B virus in hepatocytes via regulation of the ANXA2/CD40/BST2 axis.

Chen J, Chen H, Mai H, Lou S, Luo M, Xie H, Zhou B, Hou J, Jiang DK. Chen J, et al. Among authors: luo m. Hum Mol Genet. 2023 Apr 6;32(8):1334-1347. doi: 10.1093/hmg/ddac284. Hum Mol Genet. 2023. PMID: 36383401 Free PMC article.

8

CXCL13 variant predicts pegylated-interferon α treatment response in HBeAg-positive chronic hepatitis B patients.

Luo M, Zhang L, Yang C, Zhou B, Hou J, Jiang DK. Luo M, et al. J Med Virol. 2023 Jul;95(7):e28963. doi: 10.1002/jmv.28963. J Med Virol. 2023. PMID: 37470204

9

CXCR7 genetic variant predicts treatment response of pegylated-interferon α in HBeAg-positive chronic hepatitis B patients.

Luo M, Liang X, Zhou B, Hou J, Jiang DK. Luo M, et al. Antiviral Res. 2024 Nov;231:106005. doi: 10.1016/j.antiviral.2024.106005. Epub 2024 Sep 10. Antiviral Res. 2024. PMID: 39265656

10

Lipid-lowering drugs and inflammatory bowel disease's risk: a drug-target Mendelian randomization study.

Zhao J, Chen R, Luo M, Gong H, Li K, Zhao Q. Zhao J, et al. Among authors: luo m. Diabetol Metab Syndr. 2024 Jan 9;16(1):12. doi: 10.1186/s13098-023-01252-1. Diabetol Metab Syndr. 2024. PMID: 38191425 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,955 results

Search Page

Filters